Home  ›  How Could You Know if Gardasil Vaccine Caused Infertility

How Could You Know if Gardasil Vaccine Caused Infertility

Written By Tuesday, March 15, 2022 Add Comment Edit

Human papillomavirus vaccine

Gardasil
Gardasil vaccine and box new.jpg

Gardasil quadrivalent HPV [types half dozen, 11, sixteen, 18]
Vaccine description
Target For Gardasil nine: Human papillomavirus, Types vi, eleven, 16, xviii, 31, 33, 45, 52, and 58
Vaccine blazon Poly peptide subunit
Clinical data
Trade names Gardasil, Gardisil, Silgard, others
AHFS/Drugs.com Monograph
MedlinePlus a607016
Pregnancy
category
  • AU: B2[ane]
Routes of
administration		 Intramuscular injection
ATC code
  • J07BM01 (WHO) J07BM03 (WHO)
Legal condition
Legal status
  • UK: POM (Prescription only) [2]
  • US: ℞-only
  • In general: ℞ (Prescription only)
Identifiers
DrugBank
  • DB10299
  • DB10300
ChemSpider
  • none
UNII
  • 61746O90DY
  • Z845VHQ61P
KEGG
  • D10192
☒ N check Y  (what is this?) (verify)

Gardasil, technically known as recombinant human being papillomavirus vaccine [types 6, eleven, 16, 18],[3] [4] [v] [six] [7] is a vaccine for use in the prevention of certain strains of man papillomavirus (HPV), developed by Merck & Co.[viii] Loftier-risk human being papilloma virus (hr-HPV) genital infection is the most common sexually transmitted infection amongst women.[9] The HPV strains that Gardasil protects against are sexually transmitted,[x] specifically HPV types 6, eleven, sixteen and 18.[11] [12] HPV types 16 and 18 cause an estimated 70% of cervical cancers,[thirteen] [14] and are responsible for almost HPV-induced anal,[xv] vulvar, vaginal,[16] and penile cancer cases.[xv] HPV types half-dozen and 11 cause an estimated 90% of genital warts cases.[17] HPV blazon sixteen is responsible for about 90% of HPV-positive oropharyngeal cancers,[eighteen] and the prevalence is college in males than females.[eighteen] Though Gardasil does not treat existing infection, vaccination is still recommended for HPV-positive individuals, equally it may protect confronting one or more unlike strains of the affliction.[nineteen]

The vaccine was approved for medical use in the The states in 2006,[twenty] [21] initially for use in females aged 9–26.[22] In 2007, the Advisory Commission on Immunization Practices (ACIP) recommended gardasil for routine vaccination of girls aged 11 and 12 years.[23] As of August 2009, vaccination was recommended for both males and females before adolescence and the start of potential sexual activity.[xi] [24] [25] By 2011, the vaccine had been approved in 120 other countries.[26]

In 2014, the U.S. Food and Drug Administration (FDA) approved a nine-valent version, Gardasil 9, to protect against infection with the strains covered by the offset generation of Gardasil too equally 5 other HPV strains responsible for twenty% of cervical cancers (types 31, 33, 45, 52, and 58).[3] [27] [28] In 2018, the FDA approved expanded employ of Gardasil 9 for individuals aged 27 through 45 years old.[29]

Types [edit]

Gardasil is available as Gardasil which protects against 4-types of HPV (6, 11, 16, 18) and Gardasil 9 which protects against an additional v-types (31, 33, 45, 52, 58).[30]

  • Gardasil

  • Gardasil ix

Medical uses [edit]

In the United States, Gardasil is indicated for:[31]

  • girls and women ix through 45 years of historic period for the prevention of the following diseases:[31]
    • Cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by Homo Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58.[31]
    • Genital warts (condyloma acuminata) caused by HPV types vi and 11.[31]
  • girls and women 9 through 45 years of historic period for the post-obit precancerous or dysplastic lesions caused by HPV types half dozen, eleven, 16, 18, 31, 33, 45, 52, and 58:[31]
    • Cervical intraepithelial neoplasia (CIN) grade ii/3 and cervical adenocarcinoma in situ (AIS).[31]
    • Cervical intraepithelial neoplasia (CIN) grade ane.[31]
    • Vulvar intraepithelial neoplasia (VIN) form 2 and class 3.[31]
    • Vaginal intraepithelial neoplasia (VaIN) grade two and grade 3.[31]
    • Anal intraepithelial neoplasia (AIN) grades i, 2, and 3.[31]
  • boys and men 9 through 45 years of age for the prevention of the following diseases:[31]
    • Anal, oropharyngeal and other head and neck cancers caused past HPV types xvi, 18, 31, 33, 45, 52, and 58.[31]
    • Genital warts (condyloma acuminata) caused by HPV types 6 and 11.[31]
  • boys and men 9 through 45 years of historic period for the post-obit precancerous or dysplastic lesions caused by HPV types 6, 11, xvi, xviii, 31, 33, 45, 52, and 58:[31]
    • Anal intraepithelial neoplasia (Own) grades 1, 2, and 3.[31]

In the Eu, Gardasil is indicated for active immunization of individuals from the age of ix years against the post-obit HPV diseases:[6]

  • Premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine HPV types[6]
  • Genital warts (Condyloma acuminata) caused past specific HPV types.[six]

Gardasil is a vaccine to forestall HPV, that, for maximum effect, is recommended for individuals prior to their becoming sexually active.[19] Moreover, bear witness supports the determination that women who were already infected with one or more of the four HPV types targeted by the vaccine (HPV types six, xi, xvi, or xviii) were protected from clinical disease acquired by the remaining HPV types in the vaccine.[19] [ failed verification ] HPV types 16 and 18 cause an estimated seventy% of cervical cancers,[13] [14] and are responsible for about HPV-induced anal cancers.[xv] Gardasil also protects against vulvar and vaginal cancers caused by HPV types xvi and 18,[sixteen] as well as most penile cancers caused past these two HPV types.[32] Since Gardasil will not preclude infection with all of the HPV types that can cause cervical cancer, the vaccine is not considered a substitute for routine pap smears.[ commendation needed ]

In addition, protection confronting HPV types 6 and 11 may eliminate upwards to 90% of the cases of genital warts.[17] Common plantar warts—e.g., caused by HPV types one, 2, and 4[33]—are not prevented past this vaccine.

In 2010, Gardasil was approved past the FDA for prevention of anal cancer and associated precancerous lesions due to HPV types 6, eleven, 16, and 18 in people aged 9 through 26 years.[34]

HPV infections, especially HPV 16, contribute to some head and cervix cancer (HPV is found in an estimated 26–35% of caput and neck squamous cell carcinoma).[35] [36] In principle, HPV vaccines may assistance reduce incidence of such cancers acquired by HPV, only this has non been demonstrated.[37] [ needs update ] In June 2020, the FDA approved the use of Gardasil for the prevention of head and neck cancers.[38] [39]

The FDA approved Gardasil 9 for women and men aged 27 to 45 based on the vaccine being 88% effective against persistent HPV infections that crusade certain types genital warts and cancers in females. Vaccine efficacy in males in this age group was inferred.[29]

Efficacy [edit]

A 2020 longitudinal study tracking over i,600 Swedish girls and women over an xi twelvemonth menses found half as many cervical cancer cases in all women who had been vaccinated, and amidst women who had been vaccinated before the age of 17 a 78% reduction in cervical cancer, "a substantially reduced risk of invasive cervical cancer at the population level."[twoscore]

An alternative vaccine known as Cervarix protects against two oncogenic strains of HPV, xvi and 18.[41]

The National Cancer Institute says, "To date, protection against the targeted HPV types has been found to last for at least 10 years with Gardasil, at to the lowest degree nine years with Cervarix, and at to the lowest degree vi years with Gardasil 9. Long-term studies of vaccine efficacy that are still in progress will help scientists better sympathise the total duration of protection."[42]

Gardasil has been shown to be partially effective (approximately 38%) in preventing cervical cancer caused by ten other high-risk HPV types.[43]

Antibody levels at calendar month 3 (one month post-dose number two) are substantially college than at calendar month 24 (eighteen months post-dose number three), suggesting that protection is achieved by calendar month 3 and perhaps earlier.[24] In 2014, the Earth Wellness System (WHO) recommended that countries offering the vaccine in a two dose schedule to girls aged nether 15, with each dose at least six months autonomously.[17] [44] The United Kingdom, Switzerland, Mexico, and Quebec province of Canada are among the countries or territories that accept implemented this every bit of June 2015[update]. The CDC recommended the vaccines be delivered in two shots over six months.[45]

Males [edit]

Gardasil is likewise constructive in males, providing protection against genital warts, anal warts, anal cancer, and some potentially precancerous lesions caused by some HPV types.[12] [46] [47] Gardasil vaccine has been shown to subtract the risk of young men contracting genital warts.[48] In the United states, the FDA approved administration of the Gardasil vaccine to males between ages ix and 26 in 2009.[49] [50] The FDA canonical assistants of the Gardasil ix vaccine to males between ages 9 and 15 in 2014, and extended the age indication, past including males betwixt ages 16 and 26, in 2015.[51] [52] [53] In the Uk, HPV vaccines are licensed for males anile nine to xv and for females anile 9 to 26.[54]

Men who take sex with men (MSM) are especially at risk for conditions associated with HPV types 6, 11, sixteen, and xviii; diseases and cancers that have a college incidence among MSM include anal intraepithelial neoplasias, anal cancers, and genital warts. HPV blazon sixteen is as well responsible for almost xc% of HPV-positive oropharyngeal squamous-prison cell carcinoma (OPSCC),[18] a grade of cancer that affects the rima oris, tonsils, and throat;[18] [55] the prevalence of HPV-positive oropharyngeal cancers is higher in males than females.[18] A 2005 study establish that 95% of HIV-infected gay men also had anal HPV infection, of whom 50% had precancerous HPV-caused lesions.[56]

Administration [edit]

Gardasil is given in 3 injections over six months. The 2nd injection is two months after the start, and the third injection is six months later on the outset shot was administered.[11] [24] Alternatively, in some countries it is given equally two injections with at least six months betwixt them, for individuals aged 9 years up to and including 13 years.[2] [57]

Agin effects [edit]

As of April 2014[update], more than 170 million doses of Gardasil had been distributed worldwide.[58] The vaccine was tested in thousands of females (ages nine to 26).[59] The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) consider the vaccine to be safe. It does not contain mercury, thiomersal, live viruses or dead viruses, but virus-similar particles, which cannot reproduce in the man torso.[59]

The vaccine has by and large minor side effects, such as pain around the injection expanse.[59] Fainting is more common among adolescents receiving the Gardasil vaccine than in other kinds of vaccinations. Patients should remain seated for fifteen minutes after they receive the HPV vaccine.[24] There have been reports that the shot is more than painful than other common vaccines, and the manufacturer Merck partly attributes this to the virus-like particles inside the vaccine.[60] Full general side effects of the shot may include articulation and musculus pain, fatigue, concrete weakness and general malaise.[24] [61]

The FDA and the CDC said that with millions of vaccinations "by take chances lonely some serious adverse effects and deaths" will occur in the fourth dimension menstruum following vaccination, but they have null to exercise with the vaccine.[62] More than 20 women who received the Gardasil vaccine have died, just these deaths have not been causally connected to the shot, as correlation does not imply causation.[62] Where information has been available, the crusade of decease was explained by other factors.[63] [64] Likewise, a small number of cases of Guillain–Barré syndrome (GBS) have been reported following vaccination with Gardasil, though there is no bear witness linking GBS to the vaccine.[25] [65] [66] It is unknown why a person develops GBS, or what initiates the disease.[67]

The FDA and the CDC monitor events to see if there are patterns, or more serious events than would be expected from run a risk solitary.[63] The majority (68%) of side effects data were reported past the manufacturer, but in nearly 90% of the manufacturer reported events, no follow-upwardly data was given that would be useful to investigate the result further.[68] In February 2009, the Spanish Ministry of Health suspended use of 1 batch of Gardasil after wellness authorities in the Valencia region reported that two girls had get sick later on receiving the injection. Merck has stated that there was no evidence Gardasil was responsible for the ii illnesses.[69]

Ingredients [edit]

The post-obit are the ingredients found in the different formulations of HPV vaccines:[70]

  • Major capsid protein L1 epitope of HPV types 6, 11, 16, and 18 (Gardasil)
  • Major capsid protein L1 epitope of HPV types 6, eleven, xvi, xviii, 31, 33, 45, 52, and 58 (Gardasil-ix)
  • Major capsid protein L1 epitope of HPV types 16 and 18 (Cervarix)
  • amorphous aluminum hydroxyphosphate sulfate (adjuvant)
  • sodium chloride
  • yeast poly peptide
  • L-histidine
  • polysorbate lxxx
  • sodium borate[24]
  • sodium dihydrogen phosphate dihydrate (Cervarix only)
  • 3-O-Desacyl-4′-monophosphoryl lipid (MPL) A (Cervarix only)
  • Aluminum hydroxide (Cervarix merely)
  • Trichoplusia ni insect cells (Cervarix only)

Biotechnology [edit]

The HPV major capsid poly peptide, L1, can spontaneously cocky-assemble into virus-like particles (VLPs) that resemble authentic HPV virions. Gardasil contains recombinant VLPs assembled from the L1 proteins of HPV types 6, 11, xvi and eighteen. Since VLPs lack the viral DNA, they cannot induce cancer. They do, however, trigger an antibody response that protects vaccine recipients from becoming infected with the HPV types represented in the vaccine. The L1 proteins are produced by separate fermentations in recombinant Saccharomyces cerevisiae and self-assembled into VLPs.[71]

Public health [edit]

The National Cancer Institute writes:

Widespread HPV vaccination has the potential to reduce cervical cancer incidence around the world by as much equally xc%. In addition, the vaccines may reduce the need for screening and subsequent medical care, biopsies, and invasive procedures associated with follow-up from abnormal cervical screening, thus helping to reduce health care costs and anxieties related to follow-up procedures.[42]

Long-term impact and cost-effectiveness [edit]

Whether the furnishings are temporary or lifelong, widespread vaccination could take a substantial public health bear on. As of 2018, studies have proven that cervical cancer rates take dropped significantly since the introduction of Gardasil.[72] Before Gardasil was introduced in 2006, 270,000 women died of cervical cancer worldwide in 2002.[73] As of 2014, the mortality rate from cervical cancer has dropped 50% from 1975 which is due to the Gardasil vaccination along with increased focus on cervical screening.[74] Acting FDA administrator Andrew von Eschenbach said the vaccine will accept "a dramatic result" on the health of women effectually the world.[75] Gardasil is an important tool in reducing cervical cancer rates even in countries where screening programs are routine. The National Cancer Institute estimated that 9,700 women would develop cervical cancer in 2006, and 3,700 would dice.[76]

Merck and CSL Limited are expected[ needs update ] to marketplace Gardasil as a cancer vaccine, rather than an STD vaccine. In the early years of Gardasil'due south introduction it was unclear how widespread the apply of the three-shot series would be, in part because of its $525 list price ($175 each for three shots).[77] But as of 2013, vaccine coverage has been rising.[72] In 2013, well-nigh 55% of girls ages 13–17 years had at least ane dose of the vaccination covered, up from 29% in 2007. Coverage for women ages 18–34 also has increased significantly since 2007.[72]

Studies using unlike pharmacoeconomic models predict that vaccinating immature women with Gardasil in combination with screening programs may be more than price effective than screening alone.[78] These results have been important in decisions by many countries to starting time vaccination programs.[79] For case, the Canadian government approved $300 million to buy the HPV vaccine in 2008 after deciding from studies that the vaccine would exist cost-effective specially past immunizing immature women.[80] Marc Steben, an investigator for the vaccine, wrote that the fiscal burden of HPV related cancers on the Canadian people was already $300 1000000 per year in 2005, and then the vaccine could reduce this burden and be price-effective.[81]

Since penile and anal cancers are much less mutual than cervical cancer, HPV vaccination of young men is likely to be much less cost-effective than for immature women yet is nonetheless recommended due to the real risk (including oral cancer).[62]

The August 2009 consequence of the Journal of the American Medical Association had an commodity reiterating the safety of Gardasil[65] and another questioning the fashion it was presented to doctors and parents.

The new vaccine against four types of human papillomavirus (HPV), Gardasil, like other immunizations appears to exist a cost-effective intervention with the potential to enhance both adolescent wellness and the quality of their adult lives. Still, the letters and the methods by which the vaccine was marketed nowadays important challenges to physician practise and medical professionalism. By making the vaccine'due south target illness cervical cancer, the sexual transmission of HPV was minimized, the threat of cervical cancer to adolescents was maximized, and the subpopulations most at take chances practically ignored. The vaccine manufacturer also provided educational grants to professional medical associations (PMAs) concerned with adolescent and women'south health and oncology. The funding encouraged many PMAs to create educational programs and product-specific speakers' bureaus to promote vaccine use. However, much of the material did not address the full complication of the bug surrounding the vaccine and did not provide balanced recommendations on risks and benefits. As important and appropriate as it is for PMAs to advocate for vaccination equally a public good, their recommendations must be consistent with appropriate and cost-effective employ.[82]

Co-ordinate to the CDC, as of 2012, use of the HPV vaccine had cut rates of infection with HPV-6, -xi, -16 and -18 in half in American teenagers (from 11.5% to iv.3%) and by i third in American women in their early twenties (from 18.5% to 12.1%).[83]

History [edit]

Research findings that pioneered the evolution of the vaccine began in 1991 by investigators Jian Zhou and Ian Frazer in The University of Queensland, Australia. Researchers at UQ found a manner to form not-infectious virus-like particles (VLP), which could also strongly activate the immune system. Subsequently, the final grade of the vaccine was adult in parallel, by researchers at Georgetown University Medical Eye, the University of Rochester, the University of Queensland in Australia, and the U.S. National Cancer Institute.[84]

In December 2014, the FDA canonical Gardasil-9, which protects against ix strains of HPV.[85]

Society and culture [edit]

United states of america [edit]

A few conservative groups, such equally the Family Research Council (FRC), have expressed their fears that vaccination with Gardasil might give girls a false sense of security regarding sex and atomic number 82 to promiscuity,[75] [86] [87] [88] merely no bear witness exists to suggest that girls who were vaccinated went on to engage in more sexual activeness than unvaccinated girls.[89] Merck, the manufacturer of the vaccine, has lobbied that state governments make vaccination with Gardasil mandatory for school attendance,[90] which has upset some conservative and libertarian groups.[75] [91] [86]

The governor of Texas, Rick Perry, issued an executive order adding Gardasil to the state'south required vaccination list, which was later overturned past the Texas legislature. Fifty-fifty though Perry too allowed parents to opt out of the program more hands, Perry's order was criticized, past young man presidential candidates Rick Santorum and Michele Bachmann during the 2012 Republican Political party presidential debate as being an overreach of state power in a decision properly left to parents.[92]

Japan [edit]

In June 2013, the Japanese government issued a notice that "cervical cancer vaccinations should no longer exist recommended for girls anile 12 to 16" while an investigation is conducted into certain adverse events including pain and numbness in 38 girls.[93] The vaccines sold in Japan are Cervarix, made by GlaxoSmithKline of the U.k., and Gardasil, made by Merck Sharp & Dohme. An estimated three.28 meg people take received the vaccination; 1,968 cases of possible side effects have been reported.[94] In January 2014, the Vaccine Adverse Reactions Review Committee concluded that there was no evidence to suggest a causal association between the HPV vaccine and the reported adverse events, only did not reinstate proactive recommendations for its utilise.[95] A study on girls in Sapporo showed that since the Japanese government's intermission of recommending the vaccine, completion rates for the full course of vaccination have dropped to 0.vi%.[95] On Nov 26, 2021, the Ministry of Health, Labour, and Welfare of Japan officially issued an announcement to resume active recommendations of the HPV vaccine later eight.5 years of suspension and municipalities are expected to restart such agile recommendations from April, 2022. [96]

References [edit]

  1. ^ a b "Man papillomavirus vaccine Use During Pregnancy". Drugs.com. eleven February 2019. Retrieved iii April 2020.
  2. ^ a b "Gardasil nine suspension for injection - Summary of Product Characteristics (SmPC)". (emc). 24 Jan 2020. Retrieved 3 April 2020.
  3. ^ a b The nomenclature for virus types is also presented as HPV-6, HPV-11, HPV-16, HPV-18, and to HPV-31, HPV-33, HPV-45, HPV-52, and HPV-58, etc.[ citation needed ]
  4. ^ "Silgard European Public Cess Study". European Medicines Agency. 25 September 2009. Archived from the original on 25 December 2008. Retrieved 5 December 2009.
  5. ^ "Silgard EPAR". European Medicines Agency (EMA) . Retrieved iii Apr 2020.
  6. ^ a b c d "Gardasil ix EPAR". European Medicines Agency (EMA) . Retrieved 3 April 2020. Public Domain This article incorporates text from this source, which is in the public domain .
  7. ^ Waknine Y (two October 2006). "International Approvals: Singulair and Gardasil/Silgard". Medscape Today. Archived from the original on 20 May 2013. Retrieved 18 December 2008.
  8. ^ Richwine Fifty (20 August 2009). "U.S. wellness officials back safety of Merck vaccine". Reuters. Archived from the original on 27 August 2009. Retrieved 12 November 2009.
  9. ^ Gizzo South, Noventa M, Nardelli GB (September 2013). "Gardasil administration to hr-HPV-positive women and their partners". Trends in Pharmacological Sciences. 34 (9): 479–eighty. doi:ten.1016/j.tips.2013.07.001. PMID 23896431.
  10. ^ "Genital HPV Infection - Fact Canvass". www.cdc.gov. Centers for Disease Control and Prevention. Retrieved 18 April 2020.
  11. ^ a b c Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (March 2007). "Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Commission on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 56 (RR-two): i–24. PMID 17380109. Archived (PDF) from the original on 24 September 2015.
  12. ^ a b Centers for Disease Command Prevention (CDC) (May 2010). "FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Morbidity and Mortality Weekly Written report. 59 (xx): 630–2. PMID 20508594. Archived (PDF) from the original on 24 September 2015.
  13. ^ a b Lowy DR, Schiller JT (May 2006). "Prophylactic human papillomavirus vaccines". The Journal of Clinical Investigation. 116 (5): 1167–73. doi:10.1172/JCI28607. PMC1451224. PMID 16670757.
  14. ^ a b Muñoz North, Bosch FX, Castellsagué Ten, Díaz M, de Sanjose South, Hammouda D, et al. (August 2004). "Confronting which human papillomavirus types shall we vaccinate and screen? The international perspective". International Periodical of Cancer. 111 (2): 278–85. doi:10.1002/ijc.20244. PMID 15197783.
  15. ^ a b c Gao G, Smith DI (2016). "Human Papillomavirus and the Development of Different Cancers". Cytogenetic and Genome Research. 150 (three–4): 185–193. doi:10.1159/000458166. PMID 28245440.
  16. ^ a b "FDA Approves Expanded Uses for Gardasil to Include Preventing Sure Vulvar and Vaginal Cancers" (Printing release). U.S. Nutrient and Drug Administration (FDA). 12 September 2008. Archived from the original on half dozen March 2010. Retrieved 11 November 2009.
  17. ^ a b c "Human papillomavirus vaccines: WHO position paper, May 2017". Relevé Épidémiologique Hebdomadaire. 92 (19): 241–68. May 2017. hdl:10665/255353. PMID 28530369. Lay summary (PDF).
  18. ^ a b c d e Anjum, Fatima; Zohaib, Jamal (four December 2020). "Oropharyngeal Squamous Cell Carcinoma". Definitions. StatPearls (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Retrieved 7 February 2021 – via NCBI.
  19. ^ a b c "Human Papillomavirus (HPV) Vaccines". National Cancer Institute . Retrieved eighteen April 2020.
  20. ^ "Gardasil". U.S. Food and Drug Assistants. xv June 2017. Archived from the original on 22 July 2017. Retrieved 3 April 2020.
  21. ^ "FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus" (Press release). U.S. Food and Drug Administration (FDA). eight June 2006. Archived from the original on nineteen Oct 2009. Retrieved 13 November 2009.
  22. ^ "Gardasil". Britannica Academic. April 2018.
  23. ^ Moro PL, Zheteyeva Y, Lewis P, Shi J, Yue X, Museru OI, Broder K (January 2015). "Safety of quadrivalent human papillomavirus vaccine (Gardasil) in pregnancy: adverse events among non-manufacturer reports in the Vaccine Agin Event Reporting Organisation, 2006-2013". Vaccine. 33 (4): 519–22. doi:10.1016/j.vaccine.2014.11.047. PMC6524774. PMID 25500173.
  24. ^ a b c d e f "Gardasil 9- human being papillomavirus 9-valent vaccine, recombinant injection, suspension". DailyMed. Merck. twenty February 2020. Retrieved 3 April 2020.
  25. ^ a b "Gardasil Vaccine Safe". U.S. Nutrient and Drug Assistants (FDA). 20 Baronial 2009. Archived from the original on 3 May 2019. Retrieved 21 October 2019.
  26. ^ Haupt RM, Sings HL (November 2011). "The efficacy and safety of the quadrivalent homo papillomavirus half dozen/11/16/18 vaccine gardasil". The Journal of Adolescent Health. 49 (5): 467–75. doi:10.1016/j.jadohealth.2011.07.003. PMID 22018560.
  27. ^ "Gardasil 9". U.S. Food and Drug Administration (FDA). x Oct 2018. Archived from the original on 23 April 2019. Retrieved 3 Apr 2020. {{cite web}}: CS1 maint: unfit URL (link)
  28. ^ "FDA approves Gardasil ix for prevention of certain cancers acquired by five additional types of HPV". U.S. Nutrient and Drug Administration (FDA) (press release). 10 December 2014. Archived from the original on ten Jan 2015. Retrieved 28 February 2015.
  29. ^ a b "FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old". U.S. Food and Drug Administration (FDA) (Press release). 5 October 2018. Archived from the original on 14 October 2019. Retrieved xiv Oct 2018.
  30. ^ "14. Vaccines". British National Formulary (BNF) (82 ed.). London: BMJ Group and the Pharmaceutical Press. September 2022 – March 2022. pp. 1362–1390. ISBN978-0-85711-413-six.
  31. ^ a b c d due east f g h i j yard fifty m n o "Gardasil 9". U.S. Food and Drug Administration (FDA). 12 June 2020. Retrieved 15 June 2020. Public Domain This commodity incorporates text from this source, which is in the public domain .
  32. ^ Wang JW, Roden RB (February 2013). "Virus-like particles for the prevention of human papillomavirus-associated malignancies". Expert Review of Vaccines. 12 (2): 129–41. doi:ten.1586/erv.12.151. PMC3835148. PMID 23414405.
  33. ^ "Humanitas Papiloma Virus". Archived from the original on 28 February 2017. Retrieved 26 February 2018.
  34. ^ "FDA: Gardasil approved to prevent anal cancer" (Printing release). U.S. Nutrient and Drug Administration (FDA). 22 December 2010. Archived from the original on 18 December 2014. Retrieved 4 January 2011.
  35. ^ Goon PK, Stanley MA, Ebmeyer J, Steinsträsser L, Upile T, Jerjes W, et al. (Oct 2009). "HPV & head and neck cancer: a descriptive update". Head & Neck Oncology. 1 (ane): 36. doi:ten.1186/1758-3284-1-36. PMC2770444. PMID 19828033.
  36. ^ Vousden KH (1994). Jail cell transformation past human papillomaviruses. Viruses and Cancer. New York: Printing Syndicate of the University of Cambridge. pp. 27–46. ISBN9780521454728.
  37. ^ Masters C (11 May 2007). "Oral Sexual practice Tin Add to HPV Cancer Hazard". Time. Archived from the original on 4 Apr 2020.
  38. ^ "FDA Approves Merck'southward GARDASIL 9 for the Prevention of Sure HPV-Related Head and Cervix Cancers". Merck (Press release). 12 June 2020. Retrieved 15 June 2020.
  39. ^ "Gardasil Supplement Accelerated Approval" (PDF). U.S. Nutrient and Drug Administration (FDA). 12 June 2020. Retrieved xv June 2020.
  40. ^ Lei, Jiayao; Ploner, Alexander (i October 2020). "HPV Vaccination and the Risk of Invasive Cervical Cancer". New England Journal of Medicine. 2020:383 (fourteen): 1340–1348. doi:ten.1056/NEJMoa1917338. PMID 32997908.
  41. ^ Centers for Affliction Control Prevention (May 2010). "FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for employ in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Morbidity and Mortality Weekly Report. 59 (20): 626–9. PMID 20508593.
  42. ^ a b "Human being Papillomavirus (HPV) Vaccines". National Cancer Establish (NCI). 9 September 2019. Archived from the original on 4 April 2020. Retrieved 3 April 2020.
  43. ^ Schieszer J (November 2007). "HPV Vaccine Protects Against 10 "Other" Strains". Internal Medicine World Report. Archived from the original on iv December 2008.
  44. ^ World Health Organization (April 2014). "Summary of the SAGE April 2014 meeting". Archived from the original on 31 July 2015. Retrieved 2 June 2015.
  45. ^ "CDC recommends only two HPV shots for younger adolescents" (Press release). Centers for Disease Command and Prevention (CDC). 19 Oct 2016. Archived from the original on 23 March 2017. Retrieved 7 October 2017.
  46. ^ Giuliano AR, Palefsky JM, Goldstone Southward, Moreira ED, Penny ME, Aranda C, et al. (February 2011). "Efficacy of quadrivalent HPV vaccine confronting HPV Infection and disease in males". The New England Journal of Medicine. 364 (5): 401–11. doi:x.1056/NEJMoa0909537. PMC3495065. PMID 21288094.
  47. ^ Carter, Michael (vii February 2011). "Gardasil prophylactic and effective in young men". aidsmap.com. NAM aidsmap.
  48. ^ "Gay men seeking HPV vaccine". Cancer Inquiry United kingdom. 23 February 2007. Archived from the original on 24 March 2010. Retrieved 12 November 2009.
  49. ^ "FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys" (Press release). U.South. Nutrient and Drug Administration (FDA). xvi October 2009. Archived from the original on 24 Oct 2009. Retrieved 12 November 2009.
  50. ^ "October 16, 2009 Approval Letter – Gardasil". U.Southward. Food and Drug Assistants (FDA). 16 October 2009. Archived from the original on 24 Oct 2009. Retrieved 12 November 2009.
  51. ^ "FDA licensure of ix-valent human papillomavirus vaccine to include males aged 16–26 years" (PDF). U.South. Centers for Affliction Control and Prevention (CDC). 14 Dec 2015. Archived (PDF) from the original on 30 January 2017. Retrieved 10 October 2016.
  52. ^ "Provider Information: Gardasil 9 VIS" (PDF). U.South. Centers for Illness Command and Prevention (CDC). December 2015. Archived (PDF) from the original on 11 February 2017. Retrieved x Oct 2016.
  53. ^ "Highlights of Prescribing InformationI: Gardasil 9" (PDF). U.South. Food and Drug Administration (FDA). 14 Dec 2015. Archived (PDF) from the original on ten Oct 2016. Retrieved ten October 2016.
  54. ^ Roberts M (23 Feb 2007). "Gay men seek 'female cancer' jab". BBC News Online. Archived from the original on xxx January 2009. Retrieved 12 November 2009.
  55. ^ D'Souza M, Kreimer AR, Viscidi R, Pawlita One thousand, Fakhry C, Koch WM, et al. (May 2007). "Case-control report of human papillomavirus and oropharyngeal cancer". The New England Journal of Medicine. 356 (19): 1944–56. doi:10.1056/NEJMoa065497. PMID 17494927.
  56. ^ Bernard EJ (29 August 2005). "HAART is not reducing hazard of anal cancer in gay men". AIDSmap. Archived from the original on nineteen June 2006. Retrieved eight June 2006.
  57. ^ "Gardasil pause for injection - Summary of Production Characteristics (SmPC)". (emc). seven May 2019. Retrieved 3 Apr 2020.
  58. ^ McNeil Jr DG (31 March 2014). "Expansion in Utilize of Cancer Vaccine". The New York Times . Retrieved 20 December 2019.
  59. ^ a b c "HPV Vaccine Data For Immature Women". Centers for Disease Control and Prevention (CDC). Archived from the original on 28 June 2009. Retrieved 14 June 2009.
  60. ^ Stobbe One thousand (9 February 2009). "Cervical cancer shots are gaining reputation every bit painful". ABC News. Associated Press.
  61. ^ Fagan A (10 July 2008). "Merck, FDA expand Gardasil warnings". The Washington Times. Archived from the original on 17 July 2008.
  62. ^ a b c Rosenthal E (xix August 2008). "Drug Makers' Push Leads to Cancer Vaccines' Fast Rise". The New York Times. Archived from the original on 9 April 2009. Retrieved 20 August 2008.
  63. ^ a b "Information from FDA and CDC on Gardasil and its Safe (Archived)". Centers for Disease Control and Prevention (CDC). 22 July 2008. Archived from the original on 2 September 2013. Retrieved 9 September 2017.
  64. ^ "Reports of Health Concerns Post-obit HPV Vaccination". Centers for Disease Control and Prevention (CDC). 26 October 2010. Archived from the original on 17 September 2013.
  65. ^ a b Slade BA, Leidel 50, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. (August 2009). "Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine". JAMA. 302 (vii): 750–7. doi:10.1001/jama.2009.1201. PMID 19690307.
  66. ^ "HPV Vaccine – Questions & Answers for the Public". 18 July 2008. Archived from the original on 6 March 2008. Retrieved 22 August 2008.
  67. ^ "Guillain–Barré Syndrome Fact Sail". National Institute of Neurological Disorders and Stroke (NINDS). 6 May 2010. Archived from the original on 5 Baronial 2016.
  68. ^ Chustecka Z (18 August 2009). "HPV Vaccine: Debate Over Benefits, Marketing, and New Adverse Upshot Data". Medscape Today. Archived from the original on 14 November 2010. Retrieved 27 August 2009.
  69. ^ "Spain halts batch of Merck'southward Gardasil". Reuters. 10 February 2009. Archived from the original on 13 Feb 2009. Retrieved 10 Feb 2009.
  70. ^ Harper DM, DeMars LR (July 2017). "HPV vaccines - A review of the first decade". Gynecologic Oncology. 146 (1): 196–204. doi:10.1016/j.ygyno.2017.04.004. PMID 28442134.
  71. ^ "Gardasil Production Monograph" (PDF). Merck Canada Inc. Archived (PDF) from the original on 4 April 2020. Retrieved 3 April 2020.
  72. ^ a b c Jenco, Melissa (ix August 2018). "Cervical cancer declines follow HPV vaccine introduction". AAP News.
  73. ^ Cohen J (April 2005). "Public health. High hopes and dilemmas for a cervical cancer vaccine". Scientific discipline. 308 (5722): 618–21. doi:10.1126/science.308.5722.618. PMID 15860602. S2CID 31712160.
  74. ^ "Cervical Cancer: Statistics". January 2018.
  75. ^ a b c "FDA approves first vaccine for cervical cancer". NBC News. Associated Press. xvi June 2006. Retrieved 8 June 2006.
  76. ^ SEER Stat Fact Sheets: Cervix Uteri Archived 2014-07-06 at the Wayback Machine. National Cancer Establish. Retrieved xxx March 2007.
  77. ^ "Health Blue Book". Retrieved fifteen August 2012.
  78. ^ Stanley K (November 2007). "Prevention strategies confronting the human papillomavirus: the effectiveness of vaccination". Gynecologic Oncology. 107 (ii Suppl 1): S19-23. doi:x.1016/j.ygyno.2007.07.068. PMID 17938013.
  79. ^ Pallecaros A, Vonau B (Dec 2007). "Human papilloma virus vaccine--more than than a vaccine". Current Opinion in Obstetrics & Gynecology. 19 (6): 541–6. doi:10.1097/GCO.0b013e3282f1a91b. PMID 18007131. S2CID 2309744.
  80. ^ Morris SK, Nguyen CK (2008). "The homo papillomavirus vaccine in Canada". Canadian Periodical of Public Health. 99 (ii): 114–half-dozen. doi:10.1007/BF03405456. PMC6975757. PMID 18457284.
  81. ^ Steben Grand (March 2008). "Rebuttal: Do you corroborate of spending $300 million on HPV vaccination? Yeah". Canadian Family Doctor. 54 (3): 342, 344. PMC2278341. PMID 18337521.
  82. ^ Rothman SM, Rothman DJ (August 2009). "Marketing HPV vaccine: implications for adolescent health and medical professionalism". JAMA. 302 (7): 781–6. doi:x.1001/jama.2009.1179. PMID 19690311.
  83. ^ Haelle T (23 February 2016). "HPV Infection Rates Plummet In Immature Women Due To Vaccine". Forbes. Archived from the original on 26 February 2016. Retrieved 23 February 2016.
  84. ^ McNeil C (April 2006). "Who invented the VLP cervical cancer vaccines?". Journal of the National Cancer Institute. 98 (7): 433. doi:ten.1093/jnci/djj144. PMID 16595773.
  85. ^ "FDA Approves Merck'due south HPV Vaccine, GARDASIL9, to Preclude Cancers and Other Diseases Acquired past Nine HPV types – Including Types that Cause Well-nigh xc% of Cervical Cancer Cases". Merck (Press release). 11 December 2014. Archived from the original on 27 October 2017.
  86. ^ a b Fortson D (11 June 2006). "Moral majority take on GSK and Merck over cancer drugs". The Independent. Archived from the original on fourteen June 2006. Retrieved 12 June 2006.
  87. ^ Barillas Thousand (14 September 2006). "Gardasil vaccine touted in Michigan". Spero News. Archived from the original on xiv November 2006. Retrieved 26 January 2007.
  88. ^ Gaul Chiliad (2007). "Gardasil: What Parents should know nigh the new HPV vaccine" (PDF). Family Enquiry Council. Retrieved 13 September 2011.
  89. ^ Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB (Nov 2012). "Sexual practice-related outcomes later homo papillomavirus vaccination of eleven- to 12-year-olds". Pediatrics. 130 (five): 798–805. doi:10.1542/peds.2012-1516. PMID 23071201.
  90. ^ Pollack A, Saul Southward (21 Feb 2007). "Merck to halt lobbying for vaccine for girls". The New York Times . Retrieved four July 2018.
  91. ^ Houppert K (26 March 2007). "Who'due south Afraid of Gardasil?". The Nation . Retrieved 11 November 2009.
  92. ^ Gabriel T, Grady D (xiii September 2011). "In Republican Race, a Heated Boxing Over the HPV Vaccine". The New York Times. Archived from the original on 14 September 2011. Retrieved 14 September 2011.
  93. ^ Nihon Times. (sixteen June 2013). "Cervix vaccine issues trigger health observe Archived 2013-12-03 at the Wayback Machine." Accessed 9 July 2013.
  94. ^ The Asahi Shimbun. (15 June 2013). "Health ministry withdraws recommendation for cervical cancer vaccine Archived June nineteen, 2013, at the Wayback Machine." Accessed ix July 2013.
  95. ^ a b Hanley SJ, Yoshioka E, Ito Y, Kishi R (June 2015). "HPV vaccination crisis in Nippon". Lancet. 385 (9987): 2571. doi:ten.1016/S0140-6736(15)61152-7. PMID 26122153.
  96. ^ {Haruyama R, Obara H, Fujita Due north (February 2022). "Nippon resumes agile recommendations of HPV vaccine after 8·5 years of intermission". Lancet Oncology. 23 (2): 197–198. doi:10.1016/S1470-2045(22)00002-Ten. PMID 35114115. S2CID 246455402.

Farther reading [edit]

  • Silgard EPAR summary for the public
  • Shi Fifty, Sings HL, Bryan JT, Wang B, Wang Y, Mach H, et al. (February 2007). "GARDASIL: safety human papillomavirus vaccine development--from bench pinnacle to bed-side". Clinical Pharmacology and Therapeutics. 81 (2): 259–64. doi:10.1038/sj.clpt.6100055. PMID 17259949. S2CID 21647764.
  • Ireland C (2006). "A Cancer Vaccine is Built-in". Rochester Review. University of Rochester. 68 (3).
  • Harris G (30 June 2006). "Panel Unanimously Recommends Cervical Cancer Vaccine for Girls 11 and Upwards". The New York Times.
  • "Gardasil". U.Due south. Food and Drug Administration (FDA). 24 October 2019. STN: 125126.
  • "Gardasil 9". U.South. Nutrient and Drug Administration (FDA). 21 February 2020. STN: 125508.
  • Hellerstein G, Thieroff A (one February 2007). "HPV and Y'all: Girls learn most HPV from the commercials, not the classroom". The Indypendent.
  • McNeil Jr DG (29 August 2006). "How a Vaccine Search Ended in Triumph". The New York Times.

External links [edit]

  • "HPV (Human Papillomavirus) Vaccine Information Statement". U.S. Centers for Disease Control and Prevention (CDC). 30 Oct 2019.
  • Papillomavirus Vaccines at the U.s.a. National Library of Medicine Medical Subject field Headings (MeSH)
  • "Gardasil–Presence of DNA Fragments Expected, No Safe Chance". U.S. Food and Drug Administration (FDA). 2 May 2019.
  • "FDA Study-No association between VTE and Gardasil Vaccination". U.S. Food and Drug Administration (FDA). 15 April 2019.

mosleydiddlegity.blogspot.com

Source: https://en.wikipedia.org/wiki/Gardasil

0 Response to "How Could You Know if Gardasil Vaccine Caused Infertility"

Post a Comment

Subscribe to: Post Comments (Atom)

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel